An experimental drug combination was able to effectively treat pancreatic cancer in mouse models without tumor resistance.

Antibodies that bind to two targets are an established way of treating the blood cancer multiple myeloma. Aiming to top those medicines, AbbVie has secured rights to an early-clinical drug that works ...

A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published today in Nature ...

Explore new findings on drug-resistant breast cancer and how targeting cell cycle regulators may improve treatment outcomes.

A panelist discusses how antibody-drug conjugates like mirvetuximab should be sequenced in platinum-resistant ovarian cancer, recommending it as first-line therapy for folate receptor alpha–high ...

Drug resistance has long turned some of the most advanced lung cancer therapies into temporary victories, with tumors learning to shrug off chemotherapy that once held them in check. A new wave of ...

Cancer treatment resistance is one of the biggest challenges in cancer care. It occurs when cancer cells adapt to survive despite therapy, making treatments less effective or even completely ...

Ovarian cancer treatment faces challenges with high relapse and drug resistance rates, despite initial chemotherapy effectiveness. Cytokines like IL-6 and IL-11 are associated with complex tumor ...

The field of colorectal cancer (CRC) research is increasingly focused on understanding how gut microbiota and their metabolites influence therapeutic ...

File photo: — Patient Receives Chemotherapy. Source - National Cancer Institute/ Rhoda Baer (Photographer). Public Domain — CC0 1.0 Universal File photo: — Patient Receives Chemotherapy. Source - ...